Radio and PodcastLive Radio & Podcasts
Science & Medicine
Fred Aslan, Artiva CEO, on Cell Therapy’s Next Wave, RA Trials & Scalable NK Platforms
Synopsis: At the heart of JPM 2026’s biotech buzz, Alok Tayi sits down with Fred Aslan, CEO of Artiva, to explore how bold platform bets, scalable cell therapies, and autoimmune breakthroughs could reshape medicine. Fred...
About This Episode
Fred Aslan, Artiva CEO, on Cell Therapy’s Next Wave, RA Trials & Scalable NK Platforms is an episode from Biotech 2050 Podcast by Biotech2050 Podcast. Synopsis: At the heart of JPM 2026’s biotech buzz, Alok Tayi sits down with Fred Aslan, C...
Podcast
This episode belongs to Biotech 2050 Podcast.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published Feb 11, 2026, 00:25:06 long, audio available.
Related Episodes
Continue listening to more episodes from Biotech 2050 Podcast.
Ardelyx Leaders Mike Raab & Laura Williams on Building Biotech Around Patients
Jun 10, 2026 - 00:41:21
Acadia CEO Catherine Owen Adams on Neurodegeneration, AI & Building Biotech Vision
May 13, 2026 - 00:33:34
Barry Quart, CEO of Connect Biopharma, on Asthma Innovation & Biotech Leadership
Apr 16, 2026 - 00:23:07
Adial CEO Cary Claiborne on Treating Alcohol Addiction with Genetics
Mar 6, 2026 - 00:14:16
Michelle Werner, CEO of Alltrna, on tRNA Platforms, Rare Disease & Drug Innovation
Feb 10, 2026 - 00:26:40
Brian Hilberdink on Boehringer’s U.S. Growth, AI & Pharma’s Next Frontier
Jan 28, 2026 - 00:21:53